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Hematopoietic stem cells (HSCs) reside in hypoxic
niches within bone marrow and cord blood. Yet,
essentially all HSC studies have been performed
with cells isolated and processed in non-physiologic
ambient air. By collecting and manipulating bone
marrow and cord blood in native conditions of hyp-
oxia, we demonstrate that brief exposure to ambient
oxygen decreases recovery of long-term repopulat-
ing HSCs and increases progenitor cells, a phenom-
enon we term extraphysiologic oxygen shock/stress
(EPHOSS). Thus, true numbers of HSCs in the bone
marrow and cord blood are routinely underesti-
mated. We linked ROS production and induction
of the mitochondrial permeability transition pore
(MPTP) via cyclophilin D and p53 as mechanisms of
EPHOSS. The MPTP inhibitor cyclosporin A protects
mouse bone marrow and human cord blood HSCs
from EPHOSS during collection in air, resulting in
increased recovery of transplantable HSCs. Miti-
gating EPHOSS during cell collection and processing
by pharmacological means may be clinically advan-
tageous for transplantation.
INTRODUCTION
Hematopoietic stem cells (HSCs) give rise to all the blood-form-
ing elements, and their presence in bonemarrow (BM), mobilized
peripheral blood (PB), and cord blood (CB) has allowed their har-
vesting for the treatment of malignant and non-malignant disor-
ders. However, the rarity of HSCs, particularly in CB grafts, can
be a limitation of hematopoietic cell transplantation (Ballenet al., 2013). Uncoveringmechanisms in HSCbiology can identify
new strategies to enhance the number and function of HSCs and
improve engraftment efficacy. While HSCs and hematopoietic
progenitor cells (HPCs) proliferate better in vitro in hypoxia than
in normoxia (Bradley et al., 1978; Broxmeyer et al., 1985; Danet
et al., 2003; Lu and Broxmeyer, 1985; Smith and Broxmeyer,
1986), all HSC/HPC studies are performed after cell collection
and processing in ambient air (21% O2) regardless of subse-
quent processing in hypoxia or air. The BM and CB environment
where HSCs reside is extremely hypoxic compared to air (Morri-
son and Scadden, 2014; Nombela-Arrieta et al., 2013; Sjo¨stedt
et al., 1960; Spencer et al., 2014). Thus, HSC collection in air is
grossly hyperoxic compared to the BM microenvironment.
Stem cells rely heavily on glycolysis instead of mitochondrial
respiration for bioenergetic demands (Xu et al., 2013). Mouse
long-term repopulating HSCs (LT-HSCs) harbor significant
numbers of mitochondria that appear to be inactive or ‘‘nascent’’
and poised for rapid activation (Mantel et al., 2010). This is asso-
ciated with initial differentiation of quiescent LT-HSCs into ‘‘acti-
vated’’ HSCs and short-term repopulating HSCs (ST-HSCs). In
mice, this is linked to lack of CD34 expression and increased
CD150 expression (Anjos-Afonso et al., 2013; Doulatov, et. al.,
2012; Ema et al., 2006; Mantel et al., 2010) and is also thought
to involve reactive oxygen species (ROS) (Jang and Sharkis,
2007; Lewandowski et al., 2010), a normal byproduct of respira-
tion that promotes HSC differentiation (Broxmeyer and Mantel,
2012; Ito et al., 2004, 2006; Tothova and Gilliland, 2009; Yalcin
et al., 2008). We recently linked mitochondrial respiratory
dysfunction and ROS overproduction to depletion of LT-HSCs,
effects partially rescued by the ROS scavenger N-acetyl-
cysteine (Mantel et al., 2012). Therefore, we hypothesized
that suppressing ROS during HSC collection and processing
in a more physiological low O2 environment (hypoxia) might
offer protection from mitochondrial dysfunction and result in
increased HSC recovery.Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc. 1553
Figure 1. BM Harvest and Processing in Hypoxia or Ambient Air
(A) BM was harvested and processed in a hypoxic chamber (3% O2, 5% CO2, N2 balance) or ambient air (21% O2). (i) Flow cytometric density dot plots are
representative of six independent experiments. LT-HSCs are defined as CD34CD48LSK. (ii) Relative frequency histograms. Bar indicates CD34-positive or
negative staining based on isotype control antibody. (iii) Number of LT-HSCs collected, per 106 BMcells, when harvested and processed in air (A) or in the hypoxic
chamber (H); mean ± SE for six independent experiments (statistics determined by Mann-Whitney method).
(B) LT-HSCs collected from BM harvested in an hypoxic chamber and divided into two; one was removed from the chamber and immediately exposed to air for
60 min (H/A), and the other was left in the chamber for 60 min (H/H) before further staining and processing. Chart bars are mean ± SE for three independent
experiments.
(legend continued on next page)
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Here, we provide a rigorous analysis of how brief exposure of
HSCs to air affects the efficiency of HSC collection and trans-
plantation success, and we describe the molecular mechanisms
underlying it. We show that exposure to air during collection
limits the yield of HSCs from BM and CB, and we name this phe-
nomenon ‘‘extraphysiologic oxygen shock/stress’’ (EPHOSS).
EPHOSS effects are mediated by ROS production linked to
cyclophilin D (CypD), p53, and the mitochondrial permeability
transition pore (MPTP). Importantly, inhibition of EPHOSS using
cyclosporin A (CSA) enhances the yield of HSCs and the efficacy
of their transplantation. This phenomenon, suggesting that
greater numbers of HSCs reside in hematopoietic tissues and
that their in vivo metabolism is different from the one ex vivo in
air, raises questions regarding the in vivo relevance of studies
of HSCs and HPCs collected in air. Moreover, hematopoietic
cell transplantation, especially where donor HSCs are limited,
may be improved if EPHOSS is prevented or attenuated by
collection and processing of cells under hypoxia or, alternatively,
in air in the presence of CSA or through other pharmacological
targeting of the MPTP.
RESULTS
Effects of ‘‘Hypoxic Harvest’’
To limit ROS production and HSC differentiation, mouse BMwas
collected and processed under constant hypoxia (3% O2) and
compared to air-harvested BM; either one femur was harvested
inside a hypoxic chamber and the other in air, or BM was
collected in the chamber and aliquots exposed to ambient air
or left in the chamber for processing. Figure S1A shows the hyp-
oxic chamber used for these studies. Most importantly, all
reagents and supplies were equilibrated to hypoxia (3% O2) for
at least 18 hr prior to use.
Up to 5-fold greater numbers of phenotypically definedmouse
BM LT-HSCs (LinSca1+c-kit+ [LSK] CD48CD34) were re-
covered by harvesting and maintaining cells in constant hypoxia
(3% O2) compared to air (Figure 1A). Similar increases were
noted when cells were collected and processed in hypoxia
(H/H), compared to cells collected in hypoxia then placed in
air (H/A) for 60 min prior to assessment (Figure 1B), an effect(C) Length of air exposure on numbers of LT-HSCs, which were collected after ha
90 min before staining and processing (one experiment). Logistically, it was diffic
(D) Flow cytometric density dot plots of CD34 and CD150 expression in CD48
CD150+CD34CD48CD41LSK (Oguro et al., 2013). Density plots represent tw
(E) (i) ROS levels in LT-HSCs harvested and processed in ambient air (A/A) or in
ROS levels in CD48LSK; mean ± SD for three independent experiments (one m
(F) (i) Mitochondrial activities, measured by MitoTracker Green FM mean fluores
(A/A) or hypoxia (H/H); mean ± SD for three independent experiments. (ii) P
potential using JC-1 probe in BM collected and processed in ambient air or hy
(G) Numbers of LT-HSCs, short-term HSCs (ST-HSCs; CD34+CD41CD48LSK)
independent experiments (one mouse per experiment each harvested, processe
(H) Absolute numbers per femur (upper graphs) and cycling status (% in S pha
graphs) of HPCs for BM cells collected and processed in hypoxia (H/H) or coll
hypoxia (5% O2). Mean ± SE for three mice each from one experiment. *p < 0.05;
mice/group each.
(I) (i) Representative flow cytometric contour plots of human LT-HSCs (LinCD3
under hypoxic conditions with half left in hypoxia for processing (H/H) and half le
per 106 total cells; mean ± SD for four independent CB harvests.
See also Figure S1.rapidly lost if cells were exposed to air for as short as 30min (Fig-
ure 1C). This pattern was also observed if CD150 (Oguro et al.,
2013) was used to phenotypically delineate LT-HSCs instead
of CD34 (CD150+CD48CD41LSK; Figure S1B). As the
CD48CD41LSK population displays less CD34 on their sur-
face, they increase CD150 expression (Figure 1D). This verifies
that phenotypically defined mouse BM LT-HSCs are recovered
in greater numbers when harvested in hypoxia and prevented
from any exposure to air, regardless of phenotypic markers uti-
lized. ROS levels were increased in LT-HSCs and CD48 LSK
cells (containing HSCs and HPCs) harvested in air compared to
hypoxia (Figure 1E). Elevated mitochondrial activities (Figure 1Fi)
and increased numbers of primitive cells with hyperpolarized
mitochondria (Figure 1Fii) were found in air-harvested BM.
Thus, decreasedLT-HSCscorrelatedwith augmentedmitochon-
drial activity in air-exposed BM cells. Numbers of ST-HSCs
(CD34+CD48LSK cells) and multi-potent progenitors (MPPs;
CD48Linc-kit+Sca1) were increased after air exposure (Fig-
ures 1G and S1C), suggesting rapid differentiation of LT-HSCs
to ST-HSCs and HPCs in air. Hypoxic-harvested BM contained
reduced numbers and cell cycling of immature subsets of multi-
cytokine-stimulated HPCs (Figure 1H; assessed by colony as-
says), consistent with reduced ROS-mediated cytokine-induced
signaling and differentiation (Sattler et al., 1999). Thus, true
numbers and frequency of LT-HSCs, as they exist in their native
low [O2] environment, have previously been greatly underesti-
mated and numbers and cycling status of HPCs overestimated
in mouse BM. Collection/processing of mouse BM at 5% O2
did not increase numbers of HSCs as did 3% O2 (Figure S1D).
Human CB is also hypoxic compared to ambient air (Sjo¨stedt
et al., 1960). Thus, human CB was collected with syringes de-
signed to greatly minimize exposure of CB to air (Experimental
Procedures) and was typically transferred within 10 min into
the hypoxic chamber for further processing. Human-CB-derived
HSCs, identified as LinCD34+CD38CD45RACD90+CD49f+
(Notta et al., 2011; Doulatov et al., 2012), resulted in 3-fold
greater recovery compared to cells handled in air (Figure 1I),
consistent with mouse BM hypoxic harvests, suggesting exqui-
site sensitivity of HSCs to EPHOSS and demonstrating that
EPHOSS is not restricted to BM.rvest in a hypoxic chamber (zero time) and aliquots exposed to air for 30, 60, or
ult to do a time point much less than 30 min.
CD41LSK cells. With this antibody combination, LT-HSCs are defined as
o similar experiments.
hypoxia (H/H) (three independent harvests on the same day; mean ± SD). (ii)
ouse per collection per experiment on different days).
cent intensity in CD48LSK BM cells collected and processed in ambient air
ercentage of CD48LSK cells with hyperpolarized mitochondrial membrane
poxia; mean ± SD for three independent experiments.
, or multi-potent progenitors (MPPs; CD48Lin-Sca1c-kit+); mean ± SD for six
d, and analyzed on different days).
se as determined by high-specific-activity tritiated thymidine kill assay; lower
ected under hypoxia and placed in air for 60 min. (H/A) and then cultured in
**p < 0.001. Results were reproduced in four additional experiments with three
4+CD38CD45RACD90+CD49f+ as per Notta et al., 2011) from CB collected
ft in air for 60 min. (H/A). (ii) Number of phenotyped human CB-derived HSCs
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Figure 2. Competitive Mouse HSC Repopulation, HSC Homing,
Apoptosis, and CXCR4 Expression
(A) Competitive HSC engraftment. Donor cells (CD45.2+) and competitor cells
(CD45.1+; competitor cells were collected in air and injected either in hypoxia
or in air immediately after donor cells were injected) were infused into 950-cGy
irradiated dual CD45.2+/CD45.1+ F1 recipients (150,000 donor and 150,000
competitor cells). (i) BM cells were harvested in hypoxia and cells split so that
half were processed and injected in hypoxia and half subjected to air for 60min
1556 Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc.Since phenotype does not always recapitulate function, espe-
cially under stress (Broxmeyer et al., 2012), we assessed HSC
function by competitive transplantation. Mouse BM was har-
vested, processed, and injected into mice in a hypoxic chamber,
or cells were collected in hypoxia and exposed to air for >60 min
before processing and transplantation in air. A custom mouse
respiration device facilitated tail vein injection inside the hypoxic
chamber (Figure S1E). Recipient mice were only briefly (<10 s)
exposed to low O2. Competitor BM was collected in air and
infused after the donor cells. Engraftment was significantly
increasedwhen donor BMwas harvested, processed, and trans-
planted in low O2, compared to BM harvested in hypoxia and
then exposed to air (Figure 2Ai), consistent with increased
numbers of functional HSCs being present in hypoxic-harvested
BM. Low-level engraftment was seen with air-exposed donor
cells, while engraftment of hypoxia-harvested, processed, and
intravenously injected donor BM cells resulted in quite significant
enhancement in PB and BM chimerism in primary mice, as well
as enhanced repopulation in secondary mice. Two other similar
engraftment experiments were performed, including one with
‘‘air-only’’ harvest compared to ‘‘hypoxic-only’’ harvest. Chime-
rism of air-harvested donor cells was higher in the two latter ex-
periments than that shown in Figure 2Ai, even though similar
donor-to-competitor numbers were used. Combined results of
all three experiments demonstrated significant enhancement
for hypoxia-harvested, processed, and injected BM donor cells
(Figures 2Aii and S2A; competitive repopulation units [RUs], as
calculated by the method of Harrison and Astle, 1997). Limiting
dilution analysis (LDA) at month 3 for PB and month 7 or 8 for
BM performed for two of the experiments shown in Figure 2Aii
for hypoxia- versus air-harvested cells demonstrated increased
competitive repopulating units (CRUs) of 2.5- and 2.4-fold,
respectively (Figures 2Aiii and S2B). There was no significant dif-
ference in lymphoid and myeloid end-stage cell graft contribu-
tion in air- versus hypoxia-harvested, processed, and injected
cells in the engrafted mice (Figure S2C). Enhanced engraftmentprior to processing and injecting in air. Mean ± SE of CD45.2+ (donor cell)
chimerism (one experiment) for numbers of mice evaluated. Open circles,
hypoxia (H)/air (A); closed circles, (H/H). (ii) Combined results of two or
three separate engrafting studies as noted in the text. (iii) CRUs calculated
from LDA as per Antonchuk et al. (2002) (n = 3–4 mice per group at each cell
concentration infused for each of two experiments) for month 3 peripheral
blood and month 7 or 8 for BM. p value is based on Poisson statistics.
(B) Homing of cells collected in hypoxia and then left to be processed and
injected under hypoxia (H/H for input) or collected under hypoxia and
then exposed to room air for 60 min before processing and injecting cells in air
(H/A for input). Cells were analyzed 24 hr after injection by removing two
femurs plus two tibias from ten mice under hypoxia and splitting the cells into
two, one half which was left at hypoxia for staining and assessment (H/H
for output) and one half placed into air for 60 min for staining and assessment
(H/A for output). LinBMcells were injected, and%LSK cells homed (output
to input LSK) showed no significant differences in any of the groups by ANOVA
analysis.
(C) (i) Representative relative frequency histograms of CXCR4 surface staining
intensity in LT-HSCs. (ii) Mean fluorescence staining intensity of four BM
harvests (mean ± SD).
(D) Flow cytometric assessment of apoptosis using antibody to activated
caspase-3. Data represent two similar experiments.
See also Figure S2.
of hypoxic-harvested/processed cells was not due to homing
(Figure 2B; ‘‘homed’’ LSK cells were collected in hypoxia and
then analyzed either in hypoxia or 1 hr after placement in air,
with no differences noted for ‘‘homed’’ cells either way).
Enhanced engraftment did not correlate with enhanced CXCR4
expression, which was decreased on hypoxic- compared to
air-harvested LT-HSCs (Figure 2C). Apoptosis, assessed by
intracellular active caspase-3 levels, was not different when hyp-
oxic-harvested BM was exposed to air for 60 min (Figures 2D,
S2D, and S2E). So, cell death could not explain loss of HSCs
when BM was exposed to air. The picture emerging from our
studies is that harvesting donor BM in air, or even brief exposure
to air (i.e., in response to EPHOSS), has a rapid, deleterious ef-
fect on numbers and repopulating potential of HSCs.
Mechanisms of EPHOSS were assessed for biologic insights,
and as an alternative means of collecting cells to mimic effects
seen in low O2 for practical applicability. Physiological damage
from heart attack, stroke, and other ischemic events occurs
upon restoration of circulation and tissue ‘‘re-oxygenation.’’
So-called ischemia-reperfusion damage is believed to be initi-
ated by a burst of oxygen radicals rapidly produced by mito-
chondria (Kalogeris et al., 2012; Perrelli et al., 2011), with some
similarity to air BM harvest. Induction of the MPTP is implicated
in mechanisms of ischemia-reperfusion damage (Griffiths and
Halestrap, 1995; Kim et al., 2003; Lim et al., 2010). This
may be similar to what HSCs experience upon harvest in
ambient air, with induction of the MPTP via oxidative stress.
While oxidative stress favors MPTP induction resulting in mito-
chondrial swelling and OXPHOS uncoupling (Halestrap and
Davidson, 1990) leading to apoptosis and necrosis (Vaseva
et al., 2012), MPTP opening can also be intermittent/transient
and function in a regulatory capacity conducive to regulation
of differentiation of stem cells. We hypothesized that the MPTP
is involved in EPHOSS because of similarities to ischemia-
reperfusion.
MPTP Is Key to the EPHOSS Mechanism
A key regulatory component of the MPTP is peptidyl-prolyl cis-
trans isomerase, or cyclophilin D (CypD; also called cyclophilin
F), which is encoded by thePpif gene and regulatesMPTP induc-
tion (Tanveer et al., 1996). Oxidative stress facilitates recruitment
of mitochondrial CypD to the inner membrane and promotes
MPTP induction (Connern and Halestrap, 1994). CSA, a small-
molecule inhibitor of CypD, binds CypD, antagonizes MPTP
induction (Halestrap and Davidson, 1990; McGuinness et al.,
1990; Nicolli et al., 1996), and prevents ischemia-re-oxygenation
damage (Hausenloy et al., 2012). US Food and Drug Administra-
tion-approved CSA is being tested for treatment of heart attack
and stroke and is an immunosuppressant in graft versus host
disease (GVHD) for HCT (Junghanss et al., 2012; Kikuchi et al.,
2012). To test MPTP involvement in EPHOSS mechanisms,
and for possible protective effects of MPTP inhibition, BM was
harvested in air with CSA. Harvest of cells with CSA resulted
in 4-fold significant increase in recovery of LT-HSC numbers
(Figures 3A–3C). LT-HSCs declined rapidly when BM was har-
vested in air without CSA (Figure 3Ciii), consistent with kinetics
in hypoxic/air-harvest experiments (Figure 1). CSA harvest
also suppressedmulti-cytokine-induced proliferation of granulo-cyte-macrophage CFUs (CFU-GM) (Figure 3D), implicating
CypD and the MPTP in cytokine signaling/function. Delaying
addition of CSA for 15 min while collecting mouse BM in air did
not rescue the EPHOSS effect and resulted in decreased
numbers of LT-HSCs and increased numbers of ST-HSCs
and MPPs, along with increased ROS in the three cell types
(Figure S3).
Non-MPTP-related immunosuppressive CSA effects are me-
diated by inhibition of the calcineurin pathway (Liu et al., 1991).
To determine if this pathway is involved in CSA protection
against EPHOSS, BM was harvested in air with a calcineurin in-
hibitor, FK506, which does not inhibit the MPTP and is used to
address specificity of agents thought to affect the MPTP (Friberg
et al., 1998). ‘‘FK506 harvest’’ did not protect LT-HSCs from
EPHOSS (Figure 3E), confirming CSA protects LT-HSCs from
EPHOSS via suppression of the MPTP. BM was also harvested
in air in the presence of carboxyatractylate (CAT), an agent
that binds to adenine nucleotide translocase, stabilizes it in the
c-conformation, and favors MPTP opening (Halestrap and Bren-
ner, 2003). ‘‘CAT harvest’’ resulted in loss of LT-HSC recovery
(Figure 3F), which was greater than that by air harvest alone.
ROS levels were reduced in LT-HSCs and HPCs when BM was
harvested with CSA, but they increased in the presence of CAT
(Figure 3G), further supporting MPTP-opening-mediated ROS
generation in molecular mechanisms of EPHOSS. To determine
if ‘‘CSA harvest’’ protects functional HSCs from EPHOSS, we
performed competitive repopulation experiments. BM harvested
in the presence of CSA from donor mice that were pretreated
with CSA had enhanced competitive engraftment as determined
by donor cell chimerism (Figure 3Hi), CRUs from LDA (Figures
3Hii and S4A), RUs calculated by themethod of Harrison and As-
tle (1997) (Figure S4B), and enhanced secondary repopulation
(Figure 3Hi). Lymphoid and myeloid cell numbers of CSA versus
non-CSA collected, processed, and injected cells in the en-
grafted mice were similar (Figure S4C).
To assess potential clinical applicability, we performed
engraftment studies of CSA (diluted in DMSO) versus DMSO
control collection and processing of human CB. In five separate
collections, therewere increased numbers of humanCD34+ cells
and LT-HSCs and decreased MPP numbers (Figure 4A). There
was enhanced engraftment in NSG mice of CSA collected and
processed CB, as assessed by LDA for severe combined immu-
nodeficiency (SCID) repopulating cells (SRCs) (Figures 4Bi–4Biii
and S5Ai–S5Aiii), without significant differences in lymphoid and
myeloid end-stage cell graft contribution (Figure S5B). Data in
Figures 3 and 4A–4C demonstrate that regulation of the MPTP
by CypD is an important mechanism of EPHOSS, and suppres-
sion of CypD opening of the MPTP with CSA may have practical
clinical value.
The MPTP-CypD-p53 Axis Is Involved in EPHOSS
We reasoned that CypD gene deletion, which prevents MPTP
induction (Baines et al., 2005; Baines, 2010; Kalogeris et al.,
2012), might protect against EHPOSS. CypD/ mice are pro-
tected against MPTP-dependent ischemia-reperfusion damage
(Baines et al., 2005; Schinzel et al., 2005; Nakagawa et al.,
2005). LT-HSC recovery was significantly increased (Figure 4Ci),
and ROS levels in LT-HSCs significantly reduced (Figure 4Cii),Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc. 1557
Figure 3. MPTP in EPHOSS: Effects of Cyclosporin A
(A) Effects of BM harvest in air in presence of 50 mg/ml cyclosporin A (CSA-harvest) or DMSO control on CD34 expression levels in CD48-LSK cells. For the CSA
group, mice used for cell collection were injected with CSA (see Experimental Procedures). Mice in the control group were injected with control medium.
Representative flow cytometric density dot plot for three independent harvests. LT-HSCs are noted in circles.
(B) Dose-response of CSA on LT-HSC collection (n = 1 experiment).
(C) Relative frequency histogram representative of three independent harvests in DMSO or 50 mg/ml CSA. (ii) Average LT-HSCs collected after DMSO or CSA-
harvest (three independent experiments; mean ±SD). (iii) Effect of time of air exposure on BM harvested in the presence of either DMSO or CSA (one experiment).
(D) Effects of CSA or DMSO harvest on granulocyte-macrophage colony-stimulating factor (GM-CSF) plus stem cell factor (SCF)-induced CFU-GM colony
formation (mean ± SD from six mice each in a total of two experiments).
(E and F) Effects of FK506 (E) or carboxyatractylate (CAT) (F) harvests shown as a relative frequency histogram from flow cytometric data. Data in (E) and (F) are
representative of two independent experiments, each with similar results. Bar charts are quantitation (mean ± range) for two experiments.
(G) Effect of DMSO, CSA, or CAT harvest on ROS levels in CD48 LSK cells (mean of two independent experiments ± range).
(H) (i) Effect of CSA harvest, compared to DMSO (control; C) harvest, on HSC engraftment in competitive repopulation transplant assay (mean%CD45.2+ donor
cell chimerism ± SE for numbers of mice shown at each point). Results for months 1–4 and 8 for primary mice are for two experiments, while those at 1–3 months
for secondarymice are for one experiment. (ii) CRUs calculated by LDA analysis respectively at 3months for peripheral blood (PB) and at 8months for BM (n = 3–5
mice per group at each cell concentration infused for each of two experiments, mean ± SE). p value is based on Poisson statistics.
See also Figures S3 and S4.in CypD/ BM harvested in air. HPC numbers were lower in
CypD/ BM (Figure 4D), and colony formation of CFU-GM
in response to stimulation by a different multi-cytokine combi-
nation was also inhibited (Figure 4E), analogous to results of
CSA treatments (Figure 3D). This strongly implicates CypD-1558 Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc.andMPTP-mediated ROS production in cytokine signaling/stim-
ulation of HPC proliferation. Chimerism (Figure 4Fi) and LDA
to calculate CRUs, along with analysis of lymphoid/myeloid
engraftment (Figures 4Fii and S5C–S5F), demonstrated in-
creased engrafting capability of CypD/ BM HSCs without
Figure 4. Effect of Human CB CSA and Mouse BM cyclophilin D (CypD)/ Collections
(A) Effect of CSA collection on CB CD34+ cells, LT-HSCs, and MPPs. Results are from five different CB collections (mean ± SE).
(B) CRUs calculated from LDA (n = 3–5 mice per group at each cell concentration for each of two separate CB collections (mean ± SE). (Bi) Combined results of
two experiments at 2 months for PB (mean ± SE). (Bii) Results of one of the CB collections at 3.5 months for BM (mean ± SE). (Biii) Results of the other CB
collection at 4.5 months for BM (mean ± SE) (Bii and Biii results for BM were not combined, as the percent chimerism for both was largely different, precluding
averaging the results for LDA).
(C) (i) Effect of CypD gene deletion on phenotyped LT-HSC recovery when BM is harvested in air (n = 7 experiments, mean ± SE). (ii) ROS levels in LT-HSC cells
harvested from five of the seven different experiments shown in (i) (mean ± SE).
(D) Recovery of multi-cytokine-stimulated CFU-GMs, erythroid burst-forming units (BFU-Es), and CFU-GEMMs (granulocyte, erythrocyte, monocyte, and
megakaryocyte CFUs) (average of six WT and ten CypD/ mice in a total of two experiments expressed as mean ± SE).
(E) GM-CSF plus SCF-induced CFU-GM colony formation (mean ± SE) in BM from the same animals as in (D).
(F) (i) Percent PB chimerism of CypD/ BM cell engraftment at limiting dilution analysis for months 1–3 in PB and at 4.5 months in BM (four to five mice/group at
each cell concentration for one experiment; mean ±SE). (ii) CRUs as calculated formonths 2 and 3 PB andmonth 4.5 BMby LDA forCypD/BMcell engraftment
(mean ± SE).
See also Figures S4 and S5.changes in numbers of lymphoid and myeloid cells. The im-
portance of the MPTP in EPHOSS is demonstrated in Figures
4C–4F.
ROS can be produced by mitochondrial and non-mitochon-
drial sources. Mitochondrial ROS production in cells predomi-
nantly occurs in the electron transport chain and is thereforeclosely linked to respiratory activity, which in turn depends on
coupling to ATP synthesis. We wondered if CypD/ cells may
have any abnormalities in respiration and OXPHOS and if these
abnormalities could clarify mechanisms behind lower ROS gen-
eration in CypD/ cells. We used a Seahorse XF96 flux analyzer
to assess cell respiration. Because LT-HSCs are rare, we used aCell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc. 1559
surrogate hematopoietic cell, a strategy used previously (Mantel
et al., 2012). Non-mitochondrial respiration in CypD/ cells
was similar to that in wild-type (WT) cells and well coupled
to ATP synthesis as determined by inhibition of respiration
by rotenone and sensitivity to oligomycin A, respectively (Fig-
ure S6). Basal respiration and maximal respiratory capacity
was higher in CypD/ cells compared to WT cells, suggesting
a potential mechanistic link between mitochondrial electron
transport chain/respiration regulation and reduced ROS genera-
tion in hematopoietic cells in the absence of CypD.
p53 deletion is one of few gene deletions resulting in increases
in HSC numbers and engraftment (Copley et al., 2012; Nii et al.,
2012; Rossi et al., 2012). Recent findings indicate that p53 may
facilitate MPTP opening (Vaseva et al., 2012; Zhen et al.,
2014). We hypothesized that p53/ might protect HSCs from
EPHOSS by suppressing MPTP opening. We also considered
if resistance to EPHOSS could have had a role in interpretation
of results, leading to the idea that p53/ BM contains increased
HSCs. We now report that expected increases in HSC numbers
in p53/ mouse BM are not apparent with BM harvested and
assayed in 3% O2 and is only apparent when BM is harvested
and exposed to air (Figure 5A), suggesting a role for p53 in
HSC biology directly related to EPHOSS. This may influence cur-
rent concepts about the effects of p53/ onHSCbiology in vivo.
We also noted decreased numbers and cell cycle of p53/
HPCs compared to WT if BM was harvested in low [O2] and
exposed to air (Figure 5B). However, if p53/BMwas harvested
and cultured in low [O2], there were increased numbers and
cycling of progenitors compared to WT BM harvested and
cultured the same way. Therefore, analogous to effects of hyp-
oxic harvest of LT-HSCs from p53/mice (Figure 5A), interpre-
tation of effects of p53/ on functional HPC is highly dependent
on whether BM was exposed to air, and it suggests involvement
of a p53-CypD-MPTP axis in EPHOSS mechanisms.
HIF-1a, miR210, and EPHOSS
Most tissues in the human body reside in an O2 environment
considerably lower than that of ambient air. If cells/tissues
like HSCs that normally reside in low-O2 conditions are collected
and studied in ambient air, this could lead to incomplete
understanding of their biology/biochemistry unless EPHOSS is
considered.
To gain additional support for this idea, we investigated two
other gene-deletionmodels connected to the biology of hypoxia:
the hypoxamir miR210 and HIF-1a (Chan and Loscalzo, 2010;
Devlin et al., 2011; Speth et al., 2014; Zhang et al., 2012). We
wished to see if mir210 and HIF-1a may be linked to EPHOSS
and to discern if we would detect differences in HSC and HPC
numbers from these gene-knockout mice compared to control
mice when cells are collected in air versus 3% O2. Deletion of
either gene suppressed hypoxic-harvest-enhanced recovery of
LT-HSCs (Figures 5Ci and 5Cii) with amelioration of decreased
recovery of ST-HSCs and MPPs by hypoxic harvest compared
to WT controls. Hypoxic harvest of cells from control mice re-
sulted, as already shown in Figure 1H, in decreased functional
HPCs from WT BM, an effect not seen in either miR210/ or
hif-1a/ (Figures 5Di and 5Dii). These data implicate miR210
and hif-1a in EPHOSS, but they do not yet elucidate mechanistic1560 Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc.links. The experimental results obtained were dependent on
BM harvest conditions, similar to what was observed for the
CypD/ and p53/ models.
DISCUSSION
Our studies illuminate several seminal concepts. First, HSCs
from mouse BM or human CB can be collected in greater
numbers than previously recognized and that have been until
now significantly underestimated by routine harvesting and pro-
cessing in air. This information could lead to improvements
especially for CB-hematopoietic cell transplantation, where low
cell numbers collected in single units create clinical limitations
(Ballen et al., 2013). Moreover, there is a potential for rapid clin-
ical translation because CSA, which protects HSCs from
EPHOSS during air harvest via inhibition of the MPTP, is already
used clinically as an immunosuppressant.
On a more fundamental level, our study also provides insight
into the cellular effects of oxygen exposure, linking hypoxia,
CypD, and the MPTP in cytokine signaling and function and
suggesting new types of ‘‘mitochondria-centric’’ cytokine signal
transduction pathways that precisely link proliferation and differ-
entiation signals to cellular bioenergetics, metabolism, and pro-
grammed cell death via the MPTP. Moreover, using four gene-
deletion mouse models, we highlight how interpretation of
experimental results of gene-deletion models can be influenced
by EPHOSS. While CypD or p53 deletion (Figure S7) have an
EPHOSS-protective effect, miR210 and hif-1a deletion (Fig-
ure S7) abrogates protection afforded by hypoxic harvest. This
reveals a specificity of EPHOSS requirements relative to several
different factors that will have to be further evaluated.
Because different adult stem cells naturally exist in hypoxic
niches, EPHOSS may be relevant to other stem cells routinely
harvested in air. Embryonic stem cells in the inner cell mass of
blastocysts, aswell as cancer stem cells, all reside in hypoxic en-
vironments (Brown and Giaccia, 1998; Hill et al., 2009; Millman
et al., 2009; Mohyeldin et al., 2010), and ROS is important in
growth, differentiation, and regulation of these cells (Tothova
and Gilliland, 2009). Human embryonic stem cells derived from
eight-cell embryos thawed from liquid N2 under 5% O2 better
maintained pluripotency, although in those studies, embryos
were originally harvested in air (Lengner et al., 2010). Another
important point to consider here is that there is much information
about the metabolic regulation of HSCs (Suda et al., 2011), and
some may now need to be rigorously re-evaluated in the context
of EPHOSS. One example of issues arising from our findings is
that metabolic profiling for development of ‘‘personal’’ therapeu-
tic strategies to target cancer stem cells (Hsu and Sabatini, 2008;
Kamleh et al., 2011; Wood et al., 2014) may not accurately repre-
sent the metabolism of these cells as they exist in their native
hypoxic environments, because they are harvested and studied
in air. It is also possible, and indeed highly likely, that EPHOSS
will influence the metabolism and differentiation of other cell
types, including lymphocytes, monocytes/macrophages, neu-
trophils, fibroblasts, and others, since these cells also reside in
hypoxic environments.
Another point deserving exploration is the detrimental effect of
aging on HSCs and other tissue-specific stem cells (Chambers
Figure 5. Effect of p53, miR210, or hif-1a Gene Deletion
(A) Effect of p53 gene deletion on hypoxic (H/H) and air (H/A) BM harvest on phenotyped LT-HSC recovery for independent BM harvests from six p53/ and
three littermate control wild-type (WT) mice. BM from each mouse was harvested and maintained in the hypoxic chamber for 60 min before staining and fixation
(H/H) or was exposed to air for 60 min before staining and fixation (H/A). Mean LT-HSCs per 106 nucleated BM cells ± SD for each group.
(B) Effect of p53 gene deletion on multi-cytokine-stimulated progenitor cell recovery (left) or cell-cycle status (right; high-specific-activity tritiated thymidine kill
assay). BM was from the same animals harvested in (A), and cells were cultured in hypoxia (5% O2).
(C) Phenotyped LT-HSC, ST-HSC, andMPP recovery formiR210/ (i), or hif-1a/ (ii) BM. Cells from one femur were collected and processed in air (A), and cells
from the contralateral femur were collected and processed in hypoxia (H). One of two experiments with similar results for (i) and one experiment for (ii).
(D) HPC recovery from miR210/ (i) or hif-1a/ (ii) BM harvested and processed in air (A) or hypoxia (H) and cultured in hypoxia (5% O2). One of three
reproducible experiments with three mice/group (mean ± SE) for each experiment for the miR210/ mice in which one femur was collected in air and the
contralateral femur collected in hypoxia, with one of the other two experiments done in a similar manner and one experiment done with collection in hypoxia and
processing in air versus collection and processing in hypoxia. One of two reproducible experiments for hif-1a/ mice (n = 3–5, mean ± SE) with harvest in air
versus hypoxia. a, significant (p < 0.01) compared to WT A control; b, not significant (p > 0.05) compared to hif-1a/ or miR210/.
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et al., 2007; Ergen and Goodell, 2010; Mantel and Broxmeyer,
2008; Mantel et al., 2011; Sudo et al., 2000). ROS is considered
a major driver in aging (Finkel et al., 2007; Harper et al., 2004),
and it is possible that stem cells from aged animals are more
vulnerable to EPHOSS-linked ROS production when studied in
air. Thus, cells collected from aged animals or humans using ef-
forts that mitigate EPHOSS effects may have greater therapeutic
potential.
In summary, we believe that knowledge of EPHOSS will have
widespread ramifications for studies of cellular metabolism and
function in many stem/progenitor and other cell systems.
EXPERIMENTAL PROCEDURES
Animals
Mice used for most BM harvests and for transplantation were female C57BL6/
J and 6–8 weeks of age, while mice for the other experiments were males and
females with ages ranging from 6 to 20 weeks of age. Mice were age and sex
matched. In some cases, controls were littermates. Constitutive CypD/
(Ppif/) mice (B6; 129-Ppiftm/JMOL/J) were purchased from The Jackson
Laboratory. We verified knockout of CypD in hematopoietic cells by western
blotting (Figure S7A). p53/mice on a Bl/6 background were as reported pre-
viously (Jacks et al., 1994; Vemula et al., 2012), and knockout was verified by
PCR (Figure S7B). Tamoxifen-induced conditional hif1a/ mice were as pre-
viously reported, where ERT-2 Cre+Flox+/ and their ERT-2 Cre-Flox+/+ litter-
mate controls both received tamoxifen and knockout was confirmed by PCR
(Speth et al., 2014). miR210/ mice were developed in the laboratory of Na-
beel Bardeesy (Massachusetts General Hospital, Boston, MA) and successful
knockout determined by PCR (Figure S7C) (see Supplemental Experimental
Procedures). Bl/6, B6BoyJ, F1, and NSG mice were from our animal cores.
Flow Cytometry
This was done using an LSRII cytometer or FACS Calibur (Becton Dickenson)
and fluorophor-conjugated antibodies used for mouse BM cell phenotyping
(Mantel et al., 2010, 2012) (see also Figure S1C). Antibodies used for human
phenotyping (Notta et al., 2011) were anti-lineage cocktail, CD34, CD38,
CD45RA, CD90, and CD49f (BD Biosciences). For mitochondrial mass, mem-
brane potential, and ROS analysis (Mantel et al., 2010, 2012), we used Mito-
Tracker Green FM, JC-1, and MitoTracker Orange CMTMRos, respectively
(Molecular Probes, Life Technologies). CXCR4 antibodies were purchased
from BD Biosciences. Phenotyping for mouse transplant chimerism/engraft-
ment analysis was as noted (Mantel et al., 2012; Broxmeyer et al., 2012).
Flow cytometric analysis of apoptosis was assessed by activated caspase-3
(Mantel et al., 2007).
Cell Harvests
Hypoxic BM harvest was done in a custom-configured, temperature-, humid-
ity-, O2-, and CO2-controlled glove box (Figure S1A; Hypoxic Chamber, Coy)
routinely maintained at 3% O2, 5% CO2, and N2 balance. After sacrifice, ani-
mals were immediately passed into the chamber through a gassed air lock
where femurs were obtained and flushed. All solutions, media, reagents, and
plastic ware and pipet tips, and sterile gauze, as well as anything that could
come into contact with either the femur or the flushed BMcells, were pre-equil-
ibrated in the hypoxic chamber for at least 18 hr prior to use. Subsequent
procedures such as surfacemarker staining and fixation and colony assay pro-
cedures were done inside the chamber (Supplemental Experimental Proce-
dures). CSA harvests (50 mg/ml) were used for BM collection and also injected
intraperitoneally at 100 mg intomice 18–24 hr before BMharvest, although sub-
sequent experiments did not demonstrate differences in CSA collection of
HSCswhether or notmicewere injectedwith CSA before collection of BMcells
in CSA. FK506 and CAT were used at 50 mg/ml. CSA, FK506, and CAT were
purchased from Sigma.
Human CB was harvested as reported previously (Broxmeyer et al., 2006),
except airtight arterial blood gas-syringes (McKesson Medical-Surgical) equili-
brated in the hypoxic chamber were used such that exposure to air was greatly1562 Cell 161, 1553–1565, June 18, 2015 ª2015 Elsevier Inc.minimized. Syringeswere transported from the delivery room to the laboratory in
airtight plastic containers and placed back into the hypoxic chamber, often
within 10 min of collection. A portion of hypoxic-harvested CB was exposed
to air. Centrifugation of hypoxic-harvested BMandCBwas done inside the hyp-
oxic chamber or airtight tubes in tabletop centrifuges.
Collection of CB was performed within 5 min of placental delivery.
Through a single venipuncture, 15–25 ml of blood was harvested into a
60-cc syringe containing 20 ml of either PBS with heparin (H) (Sigma
#H3393) at 1,000 U/ml and CSA (Sigma #P500092) at 50 mg/ml or PBS/H
with DMSO (D) at equivalent volume of CSA. Each collection was immediately
added respectively to 50 ml of either PBS/H/CSA or DPBS/H/D in a sterile
container and mixed thoroughly. Blood was further processed for mononu-
clear cells and enriched for CD34 cells using standard protocols for Ficoll sep-
aration and micro-bead isolation with all solutions respectively containing
either CSA at 50 mg/ml or equivalent volume of DMSO.
All studies using human cells were approved by the institutional review
board of the Indiana University School of Medicine.
Transplantation
Recipient F1 and NSGmice were continuously fed uniprim feed and irradiated
with one dose of 950 or 300 cGy, respectively, 24 hr prior to transplantation
with engraftment (Broxmeyer et al., 2012), as detailed in the figure legends.
Homing is described in Supplemental Experimental Procedures.
Limiting Dilution Analysis
The frequency of mouse CRUs and human SRCs was analyzed by LDA as pre-
viously reported (Antonchuk, et al. 2002; Boitano, et al., 2010). For mouse ex-
periments, increasing doses of C57BL/6 BM cells (CD45.2+) with B6 BoyJ
(CD45.1+) competitor cells were transplanted into lethally irradiated (950
cGy) F1 (CD45.2/CD45.1+) recipient mice. For human experiments, increasing
doses of CD34+ cells were infused into sublethally irradiated (300 cGy) NSG
mice. For each LDA experiment, mice were transplanted with either of three
cell concentrations, with the second being half of the first and the third being
half of the second. Numbers of mice for each dilution are given in the figure leg-
ends. HSC frequencywas calculated using L-Calc software (STEMCELL Tech-
nologies) and plotted using ELDA software (http://bioinf.wehi.edu.au/
software/elda/). Poisson statistics was used to calculate the p value for all
LDA analyses.
Colony Assays and Tritiated Thymidine Kill Assay
These assays were done as reported elsewhere (Broxmeyer et al., 2012;
Mantel et al., 2012). Colonies were scored after incubation at 5% O2, 5%
CO2 to maximize detectable colony numbers.
Respirometry
Extracellular flux respirometry was done on mouse splenocytes as reported
previously (Mantel et al., 2012).
Statistics
Statistical analysis was done using a two-tailed student t test or, where indi-
cated, by ANOVA or a Mann-Whitney test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2015.04.054.
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